Search research articles
Contact Us
Filters
Showing results (91-100 of 123) with videos related to
Page
of 13
Sort By:
Cancer Medicine
|
April 6, 2023
Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies
Ruben A Mesa, Stacie Hudgens, Lysbeth Floden, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2012
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21
Anindita Roy, Gillian Cowan, Adam J Mead, et al.
Blood Advances
|
April 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study
Harinder Gill, Abdulraheem Yacoub, Aaron T Gerds, et al.
Blood
|
March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AML
Zhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Blood
|
January 18, 2018
Canonical Notch signaling is dispensable for adult steady-state and stress myelo-erythropoiesis
Sara Duarte, Petter S Woll, Natalija Buza-Vidas, et al.
Cell Stem Cell
|
February 24, 2026
comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders
Yuqi Shen, Camelia Benlabiod, Edmund Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2023
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, et al.
Cancer Research
|
November 3, 2023
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts
Pedro L Moura, Teresa Mortera-Blanco, Isabel J Hofman, et al.
Future Oncology (London, England)
|
August 11, 2022
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, et al.
Nature Immunology
|
October 4, 2016
Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors
Tiago C Luis, Sidinh Luc, Takuo Mizukami, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 123) with videos related to
Sort By:
Page
of 13
Cancer Medicine
|
April 6, 2023
Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies
Ruben A Mesa, Stacie Hudgens, Lysbeth Floden, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2012
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21
Anindita Roy, Gillian Cowan, Adam J Mead, et al.
Blood Advances
|
April 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study
Harinder Gill, Abdulraheem Yacoub, Aaron T Gerds, et al.
Blood
|
March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AML
Zhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Blood
|
January 18, 2018
Canonical Notch signaling is dispensable for adult steady-state and stress myelo-erythropoiesis
Sara Duarte, Petter S Woll, Natalija Buza-Vidas, et al.
Cell Stem Cell
|
February 24, 2026
comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders
Yuqi Shen, Camelia Benlabiod, Edmund Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2023
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, et al.
Cancer Research
|
November 3, 2023
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts
Pedro L Moura, Teresa Mortera-Blanco, Isabel J Hofman, et al.
Future Oncology (London, England)
|
August 11, 2022
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, et al.
Nature Immunology
|
October 4, 2016
Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors
Tiago C Luis, Sidinh Luc, Takuo Mizukami, et al.
Page
of 13